Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time

Autor: Michael H Weisman, John D Reveille, MinJae Lee, Lianne S Gensler, Michael M Ward, Mariko Ishimori, Karim Doughem, Amirali Tahanan, David C Kung, Laura Diekman, Mohammad Hossein Rahbar

Publikováno v: RMD Open, Vol 6, Iss 3 (2020)

Background/Purpose First-degree relatives (FDRs) of patients with ankylosing spondylitis (AS) may be at high risk of spondyloarthritis. We examined the frequency, characteristics of chronic back pain (CBP), associated features, persistence of symptom

Externí odkaz: https://doaj.org/article/565b0960c1d84933958f276292d25d4b

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review

Autor: Bader Madoukh, Ayman Battisha, Karim Doughem, Mohammed Al-Sadawi, Omar Sheikh, Lakshmi Konduru, Shakil Shaikh

Publikováno v: Current Cardiology Reviews. 17:182-187

Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs. It is generally well-tolerated and has a safe profile in pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04944974eabbea714a65b5fbbb9cd0c6
https://doi.org/10.2174/1573403x16666200518092814

Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis) Commencing Late in Life.

Autor: Hwang MC; Mark C. Hwang, MD, MS, Division of Rheumatology, Department of Internal Medicine, John P. and Katherine G. McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Doughem K; Karim Doughem, MD, Division of Rheumatology, Department of Internal Medicine, John P. and Katherine G. McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Lee M; MinJae Lee, PhD, Peter O'Donnell Jr. School of Public Health - University of Texas Southwestern Medical Center, Dallas, Texas, USA., Gensler LS; Lianne S. Gensler, MD, Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, California, USA., Ishimori ML; Mariko L. Ishimori, MD, Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Ward MM; Michael M. Ward, MD, MPH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Brown MA; Matthew A. Brown, MD, PhD, Guy's and St Thomas' NHS Foundation Trust, and King's College London NIHR Biomedical Research Centre, London, UK., Tahanan A; Amirali Tahanan, MS, Biostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences, Department of Internal Medicine, John P. and Katherine G. McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Weisman MH; Michael H. Weisman, MD, Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Rahbar MH; Mohammad H. Rahbar, PhD, Biostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences, Department of Internal Medicine, John P. and Katherine G. McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Reveille JD; John D. Reveille, MD, Division of Rheumatology, Department of Internal Medicine, John P. and Katherine G. McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.